Capital Fund Management »

Royalty Pharma shares owned by Capital Fund Management

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Capital Fund Management from 13F filings

Historical chart of Capital Fund Management investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Capital Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Capital Fund Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.8M 176k 27.14

More positions owned by Capital Fund Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Tesla Motors Call Option (TSLA)
Nike CL B (NKE)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A Call Option (META)
Select Sector Spdr Tr Energy (XLE)
Exxon Mobil Corporation (XOM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Target Corporation (TGT)
Bank of America Corporation (BAC)
Adobe Systems Incorporated (ADBE)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
salesforce (CRM)

View all positions for Capital Fund Management

Top funds holding Royalty Pharma

Vanguard Group
Baillie Gifford & Co
Viking Global Investors
Jpmorgan Chase & Co
Unisphere Establishment
Norges Bank Investment Management
Amundi
Siguler Guff Advisers
Legal & General Group
Goldman Sachs Group
Man Group
CalPERS
Two Sigma Investments
Two Sigma Advisers
Henderson Group

View all funds holding Royalty Pharma